These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6712730)

  • 1. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
    Thayer WS
    Biochem Pharmacol; 1984 Apr; 33(8):1187-94. PubMed ID: 6712730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ammonium inhibition of fatty acid oxidation in rat liver mitochondria. A possible cause of fatty liver in Reye's syndrome and urea cycle defects.
    Maddaiah VT
    Biochem Biophys Res Commun; 1985 Mar; 127(2):565-70. PubMed ID: 3977937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine metabolism in rats with 4-pentenoic acid induced fatty liver.
    Yuge K
    Acta Paediatr Jpn; 1990 Aug; 32(4):449-55. PubMed ID: 2288228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ammonium chloride inhibits pyruvate oxidation in rat liver mitochondria: a possible cause of fatty liver in Reye's syndrome and urea cycle defects.
    Maddaiah VT; Kumbar U
    Clin Sci (Lond); 1994 Nov; 87(5):499-503. PubMed ID: 7874836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of L-carnitine supplementation in 4 pentenoic acid treated rats.
    Sugimoto T; Woo M; Nishida N; Araki A; Murakami K; Kobayashi Y
    Brain Dev; 1990; 12(4):417-22. PubMed ID: 2240462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of methylglyoxal bis(guanylhydrazone) on hepatic, heart and skeletal muscle mitochondrial carnitine palmitoyltransferase and beta-oxidation of fatty acids.
    Brady LJ; Brady PS; Gandour RD
    Biochem Pharmacol; 1987 Feb; 36(4):447-52. PubMed ID: 3827937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvesicular fatty liver in rats with resembling Reye's syndrome induced by 4-pentenoic acid.
    Sakaida N; Senzaki H; Shikata N; Morii S
    Acta Pathol Jpn; 1990 Sep; 40(9):635-42. PubMed ID: 2260472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of valproic acid on the expression of various acyl-CoA dehydrogenases in rats.
    Kibayashi M; Nagao M; Chiba S
    Pediatr Int; 1999 Feb; 41(1):52-60. PubMed ID: 10200137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in plasma amino acids and hepatic enzymes in the 4-pentenoic acid model of Reye's syndrome.
    Hart MA; Swisher JA; Caspers ML
    Biochem Pharmacol; 1989 May; 38(10):1696-8. PubMed ID: 2730684
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.
    Deschamps D; Fisch C; Fromenty B; Berson A; Degott C; Pessayre D
    J Pharmacol Exp Ther; 1991 Nov; 259(2):894-904. PubMed ID: 1941634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of glucagon treatment and starvation of virgin and lactating rats on the rates of oxidation of octanoyl-L-carnitine and octanoate by isolated liver mitochondria.
    Zammit VA
    Biochem J; 1980 Aug; 190(2):293-300. PubMed ID: 7470052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of mitochondrial fatty acid oxidation by 2-bromopalmitate and its coenzyme A and carnitine esters.
    Chase JF; Tubbs PK
    Biochem J; 1972 Aug; 129(1):55-65. PubMed ID: 4646779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some aspects of fatty acid oxidation in isolated fat-cell mitochondria from rat.
    Harper RD; Saggerson ED
    Biochem J; 1975 Dec; 152(3):485-94. PubMed ID: 1227502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of beta-oxidation by 3-mercaptopropionic acid produces features of Reye's syndrome in perfused rat liver.
    Yamamoto M; Nakamura Y
    Gastroenterology; 1994 Aug; 107(2):517-24. PubMed ID: 8039627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic.
    Fréneaux E; Labbe G; Letteron P; The Le Dinh ; Degott C; Genève J; Larrey D; Pessayre D
    Hepatology; 1988; 8(5):1056-62. PubMed ID: 3417225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of peroxidized polyunsaturated fatty acids on mitochondrial function and structure: pathogenetic implications for Reye's syndrome.
    Brown RE; Bhuvaneswaran C; Brewster M
    Ann Clin Lab Sci; 1988; 18(4):337-43. PubMed ID: 2900617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the effects of saturated and unsaturated short-chain monocarboxylic acids on the energy metabolism of rat liver mitochondria.
    Gregersen N
    Pediatr Res; 1979 Nov; 13(11):1227-30. PubMed ID: 514688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mitochondrial functions by margosa oil: possible implications in the pathogenesis of Reye's syndrome.
    Koga Y; Yoshida I; Kimura A; Yoshino M; Yamashita F; Sinniah D
    Pediatr Res; 1987 Aug; 22(2):184-7. PubMed ID: 3658544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical effects of the hypoglycaemic compound pent-4-enoic acid and related non-hypoglycaemic fatty acids. Effects of the free acids and their carnitine esters on coenzyme A-dependent oxidations in rat liver mitochondria.
    Holland PC; Sherratt HS
    Biochem J; 1973 Sep; 136(1):157-71. PubMed ID: 4772622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic metabolic alterations in rats treated with low-dose endotoxin and aspirin: an animal model of Reye's syndrome.
    Kilpatrick LE; Polin RA; Douglas SD; Corkey BE
    Metabolism; 1989 Jan; 38(1):73-7. PubMed ID: 2909830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.